We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $481M
1-Year Est. Return 35.73%
This Fund
S&P 500
This Quarter Est. Return
+1.38%
1 Year Est. Return
+35.73%
3 Year Est. Return
+116.09%
5 Year Est. Return
+167.64%
10 Year Est. Return
+1,066.43%
AUM
$349M
AUM Growth
-$2.6M
Cap. Flow
-$4.7M
Cap. Flow %
-1.35%
Top 10 Hldgs %
72.52%
Holding
51
New
4
Increased
8
Reduced
32
Closed
2

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.41M
2
AZN icon
AstraZeneca
AZN
+$2.71M
3
IDXX icon
Idexx Laboratories
IDXX
+$339K
4
AMD icon
Advanced Micro Devices
AMD
+$290K
5
NOW icon
ServiceNow
NOW
+$245K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$4.11M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.67M
3
AAPL icon
Apple
AAPL
+$770K
4
ISRG icon
Intuitive Surgical
ISRG
+$393K
5
BAND
Bandwidth Inc
BAND
+$371K

Sector Composition

Rank Sector Weight
1 Technology 33.37%
2 Consumer Discretionary 29.92%
3 Healthcare 21.28%
4 Communication Services 12.55%
5 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALXN
51
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-22,373
Closed -$4.11M
1 2
3

Similar funds

MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $481M AUM 22.61% 1-Year Est. Return
SA
Stewardship Advisors Mount Joy, Pennsylvania $481M AUM 18.41% 1-Year Est. Return
NC
NovaPoint Capital Atlanta, Georgia $481M AUM 32.01% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $481M AUM 20.5% 1-Year Est. Return
MAV
Mason & Associates (Virginia) Newport News, Virginia $481M AUM 12.85% 1-Year Est. Return
OMIC
Old Mission Investment Co Traverse City, Michigan $481M AUM
SCA
Sage Capital Advisors Sioux Falls, South Dakota $482M AUM 34.73% 1-Year Est. Return

Bender Robert & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Bender Robert & Associates held 51 positions worth $349M, down 0.74% from $352M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bender Robert & Associates's Q3 2021 filing shows 4 new, 8 increased, 32 reduced and 2 closed positions. Its largest new stake was AstraZeneca: 23,290 shares worth $2.8M. The largest sale was Alexion Pharmaceuticals, an estimated $4.11M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q3 2021 buy was AstraZeneca: 23,290 shares worth $2.8M.
  • Bender Robert & Associates added most to Alphabet (Google) Class C in Q3 2021, an estimated $3.41M increase.
  • Bender Robert & Associates's biggest Q3 2021 reduction was Alphabet (Google) Class A, cutting an estimated $3.67M.
  • Bender Robert & Associates fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.11M.
  • Bender Robert & Associates's ten largest holdings make up 73% of its $349M portfolio in Q3 2021.
  • Bender Robert & Associates opened 4 new positions and closed 2 in Q3 2021.
  • Bender Robert & Associates's portfolio value fell 0.74% quarter-over-quarter to $349M.

Based on Bender Robert & Associates's 13F filing for Q3 2021, filed 3 Nov 2021.